NEOGEN CORP

NEOG

{{popupValue}}
{{popupSubtitle}}

Identification

Click on a field for details on how to access that data via Web API, Excel, or CSV Download.

Ticker
NEOG
CIK0000711377
SIC2835
SectorManufacturing
Industry CategoryPharmaceutical Products
Industry GroupIn Vitro, In Vivo Diagnostic Substances

Contact

Address620 LESHER PLACE, LANSING, MI, 48912
Website neogen.com
Phone5173729200
CEOJohn E. Adent
Employees2,110

Access This Data

Our team will help you customize a package that meets the needs of your business.

Request a Consultation

Standardized Financials

docs

Intrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals.

For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards.

Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics:

Income Statement
Revenue$924.22 million
Pre-Tax Income$-14.30 million
Net Income$-9.42 million
Net Income to Common$-9.42 million
EPS$-0.04
View All
Balance Sheet
Cash$127.70 million
Assets$4.04 billion
Liabilities$1.38 billion
Common Equity$2.66 billion
Liabilities & Equity$4.04 billion
View All
Cash Flow Statement
Calculations
NOPAT$41.06 million
EBITDA$177.40 million
Price to EarningsN/A
Price to Book$0.34
ROE-0.30%
View All

Latest News

docs

Intrinio provides up-to-date news articles on every US company from various sources. Here are several examples:

NeoGenomics, RadNet, Pediatrix Medical Group, Penumbra, and Neogen Shares Plummet, What You Need To Know

A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada.

Article Link

Neogen Announces Fourth-Quarter Earnings Release Date

LANSING, Mich., July 08, 2025--Neogen® Corporation (NASDAQ: NEOG) will issue its fourth-quarter earnings release before the opening of the market on Tuesday, July 29, 2025. Executives from the company will host a webcast and conference call later that morning, beginning at 8:00 a.m. Eastern time, to discuss the financial results.

Article Link

Medical Devices & Supplies - Diversified Stocks Q1 Teardown: CooperCompanies (NASDAQ:COO) Vs The Rest

Looking back on medical devices & supplies - diversified stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including CooperCompanies (NASDAQ:COO) and its peers.

Article Link

Bullish Neogen Insiders Loaded Up On US$1.44m Of Stock

It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it...

Article Link

1 Volatile Stock to Target This Week and 2 to Be Wary Of

Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability can shake out even the most experienced investors.

Article Link